Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Cell Cycle (Georgetown, Tex.)|October 16, 2010
APC/C(Cdc20) targets E2F1 for degradation in prometaphaseMelissa J Peart, Masha V Poyurovsky, Elizabeth M Kass, et al.
Molecular Cell|May 21, 2011
Deubiquitinase USP37 is activated by CDK2 to antagonize APC(CDH1) and promote S phase entryXiaodong Huang, Matthew K Summers, Victoria Pham, et al.
Cancers|June 28, 2023
Improving Localized Radiotherapy for Glioblastoma via Small Molecule Inhibition of KIF11Miranda M Tallman, Abigail A Zalenski, Ian Stabl, et al.
The Journal of Biological Chemistry|September 12, 2021
The deubiquitinating enzyme USP37 enhances CHK1 activity to promote the cellular response to replication stressBenjamin R Stromberg, Mayank Singh, Adrian E Torres, et al.
Cancer Letters|November 30, 2020
The small molecule drug CBL0137 increases the level of DNA damage and the efficacy of radiotherapy for glioblastomaMiranda M Tallman, Abigail A Zalenski, Amanda M Deighen, et al.
Science Translational Medicine|September 11, 2015
The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastomaMonica Venere, Craig Horbinski, James F Crish, et al.
Cell|December 14, 2011
The STARD9/Kif16a kinesin associates with mitotic microtubules and regulates spindle pole assemblyJorge Z Torres, Matthew K Summers, David Peterson, et al.
Cancer Research|February 15, 2020
LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane ResistanceMelyssa S Roberts, Jennifer M Sahni, Morgan S Schrock, et al.
Cancer Research|August 16, 2017
Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET InhibitorsJennifer M Sahni, Sylvia S Gayle, Bryan M Webb, et al.
Pageof 4